P849: Genetic variation within the NKG2D pathway may influence the response to anti-NKG2D therapy in Crohn’s diseaseECCO '18 Vienna
2018
P850: Genetic variants of MGAT5 gene are associated with ulcerative colitis severity and response to therapyECCO '18 Vienna
2018
P851: Oral delivery of Human β-defensin 2 is reversibly increasing microbiome diversity and is effective in the treatment of experimental colitisECCO '18 Vienna
2018
P852: A metabolomics approach to discover biomarkers of chronic intestinal inflammation associated with gut microbiota dysbiosis in ulcerative colitis and Celiac DiseaseECCO '18 Vienna
2018
P853: Immunoglobulin G selectively binds pathobionts in the terminal ileum of paediatric IBD patientsECCO '18 Vienna
2018
P854: Quantitative microbiome profiling changes the described dysbiotic state in inflammatory bowel diseaseECCO '18 Vienna
2018
P855: Vegetarian and gluten-free diet in patients with IBD—associated with a different microbiota compared with omnivore IBD patientsECCO '18 Vienna
2018
P857: Dysbiosis and ecotypes of the salivary microbiome associated with inflammatory bowel diseases and the assistance in diagnosis of diseases using oral bacterial profilesECCO '18 Vienna
2018
P859: The functional exoproteome as a driver and predictor of IBD status: Proteases from bacteria influence host healthECCO '18 Vienna
2018
P860: Combination of prebiotic FOS and adalimumab for prevention of dysbiosis in active Crohn’s disease: A pilot studyECCO '18 Vienna
2018
P861: Short-chain fatty acids as a marker of intestinal dysbiosis in patients with inflammatory bowel diseasesECCO '18 Vienna
2018
P862: Colonisation of viable bacteroidetes in fresh or frozen faecal microbiota transplantationECCO '18 Vienna
2018
P863: Eradication of dysbiotic indigenous species by multiple antibiotic pre-treatment contribute to effective faecal microbiota transplantationECCO '18 Vienna
2018
P864: A microfluidic-based human gut-on-a-chip for 3D organ and disease modellingECCO '18 Vienna
2018
P865: The protective effect of Saccharomyces boulardii on intestinal mucosal barrier of inflammatory bowel diseaseECCO '18 Vienna
2018
P866: Faecal microbiota in newly diagnosed Crohn’s disease and its relation to treatment escalationECCO '18 Vienna
2018